sub:assertion {
d:DB00759 dv:ddi-interactor-in dr:DB00759_DB00930 .
d:DB00930 dv:ddi-interactor-in dr:DB00759_DB00930 .
dr:DB00759_DB00930 dct:identifier "drugbank_resource:DB00759_DB00930" ;
dct:title "DDI between Tetracycline and Colesevelam - Bile acid sequestrants such as colesevelam may decrease the absorption of Tetracycline Derivatives. Monitor for decreased therapeutic effects of tetracycline derivatives if coadministered with a bile acid sequestrant. If these agents are used concomitantly, separate doses 2 or more hours to minimize the interaction. The manufacturer of colesevelam suggests that drugs should be administered at least 1 hour before or 4 hours after colesevelam."@en ;
a dv:Drug-Drug-Interaction ;
rdfs:label "DDI between Tetracycline and Colesevelam - Bile acid sequestrants such as colesevelam may decrease the absorption of Tetracycline Derivatives. Monitor for decreased therapeutic effects of tetracycline derivatives if coadministered with a bile acid sequestrant. If these agents are used concomitantly, separate doses 2 or more hours to minimize the interaction. The manufacturer of colesevelam suggests that drugs should be administered at least 1 hour before or 4 hours after colesevelam. [drugbank_resource:DB00759_DB00930]"@en .
}